SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-18-350025
Filing Date
2018-12-14
Accepted
2018-12-14 17:17:05
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-3 d672650ds3.htm S-3 285309
2 EX-4.3 d672650dex43.htm EX-4.3 30252
3 EX-4.4 d672650dex44.htm EX-4.4 260738
4 EX-5.1 d672650dex51.htm EX-5.1 27469
5 EX-23.1 d672650dex231.htm EX-23.1 1919
6 EX-23.2 d672650dex232.htm EX-23.2 1559
7 GRAPHIC g672650g20g56.gif GRAPHIC 7067
  Complete submission text file 0001193125-18-350025.txt   618368
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-3 | Act: 33 | File No.: 333-228831 | Film No.: 181236399
SIC: 2834 Pharmaceutical Preparations